Groups vulnerable to these deficiencies include individuals dealing with obesity, impaired nutrient absorption, renal issues, proton pump inhibitor (PPI) users, elderly individuals with elevated Clinical Frailty Scores, women, taller individuals, and post-bariatric surgery patients, especially those lacking postoperative care [3, 43,44,45]
Summary of Glucagon-like Peptide-1 Receptor Agonists for Adults * * GLP-1 RAs share the same underlying mechanism of action, but they differ in terms of formulations, administration, injection devices and dosages
Adults of any age can consider using semaglutide, but older adults should be sure to consult their doctors before engaging in any weight loss efforts, cautions Garvey
When Eli Lilly published retatrutide's Phase 2 trial results in the New England Journal of Medicine in June 2023, the numbers got attention: participants on the highest dose lost an average of 24.2% of their body weight over 48 weeks
Roche, AstraZeneca, Viking Therapeutics, and Structure Therapeutics all have promising oral or next-generation programs in development